It anticipates the prediabetes and diabetes stages characterized by hyperglycemia among other glucocentric biomarkers Lima LMTR 2017 Subclinical Diabetes.
It anticipates the prediabetes and diabetes stages characterized by hyperglycemia among other glucocentric biomarkers. It may affect 140 million people worldwide Lima LMTR 2017 Subclinical Diabetes.